The UK’s Biotechnology Association (BIA) and Japan’s Forum for Innovative Regenerative Medicine (FIRM) have agreed a collaboration.
Their partnership is aimed at helping UK and Japanese companies in the regenerative medicine and cell and gene therapy sectors to work together.
The collaboration was announced at a meeting between the BIA and FIRM, at which topics discussed included the UK’s imminent departure from the European Union, and reimbursement models.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze